Emvision Medical Devices Ltd (EMV) — Cash Flow Reinvestment Rate

Latest as of December 2022: 0.01x

Emvision Medical Devices Ltd (EMV) has a Cash Flow Reinvestment Rate of 0.01x as of December 2022, reinvesting AU$20.23K (capex AU$20.23K ) from operating cash flow of AU$2.92 Million. Explore EMV cash generation efficiency to assess how effectively this company generates cash.

Reinvestment Rate

0.01x

(Capex + Investments) / Operating CF

Total Reinvested

AU$20.23K

Capex + Investments

Operating Cash Flow

AU$2.92 Million

AUD

Capital Expenditures

AU$20.23K

AUD

Emvision Medical Devices Ltd Cash Flow Reinvestment Rate (2023–2023)

Historical reinvestment intensity for Emvision Medical Devices Ltd across 1 annual periods. Explore EMV debt coverage from operations to assess how comfortably operating cash covers total debt obligations.

Annual Cash Flow Reinvestment Rate for Emvision Medical Devices Ltd (2023–2023)

Year-by-year capital reinvestment analysis for Emvision Medical Devices Ltd. For live market cap and broader valuation context, see EMV company net worth.

Year	Reinvestment Rate	Total Reinvested (AUD)	Operating CF	Capex	YoY Change
2023	0.45x	AU$374.59K	AU$834.15K	AU$187.29K	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow